As shown in Figure 4A, NB and AVM tissue expressed similarly lower levels of SMAD4 mRNA compared to CCMs, consistent with the previously reported activated TGF‐β signaling in CCM tissue.17, 18. This evidence concerns the gene SMAD4 and cerebral cavernous malformation.